A 0 1 0 1 O
positive 2 10 2 10 O
hepatitis 11 20 11 20 B-chronic_disease
B 21 22 21 22 I-chronic_disease
serology 23 31 23 31 O
indicative 32 42 32 42 O
of 43 45 43 45 O
previous 46 54 46 54 B-treatment
immunization 55 67 55 67 I-treatment
( 68 69 68 69 O
i.e. 69 73 69 73 O
, 73 74 73 74 O
hepatitis 75 84 75 84 O
B 85 86 85 86 O
surface 87 94 87 94 O
antibody 95 103 95 103 O
[ 104 105 104 105 O
HBsAb 105 110 105 110 O
] 110 111 110 111 O
positive 112 120 112 120 O
and 121 124 121 124 O
hepatitis 125 134 125 134 O
B 135 136 135 136 O
core 137 141 137 141 O
antibody 142 150 142 150 O
[ 151 152 151 152 O
HBcAb 152 157 152 157 O
] 157 158 157 158 O
negative 159 167 159 167 O
) 167 168 167 168 O
, 168 169 168 169 O
or 170 172 170 172 O
a 173 174 173 174 O
fully 175 180 175 180 O
resolved 181 189 181 189 O
acute 190 195 190 195 O
HBV 196 199 196 199 B-chronic_disease
infection 200 209 200 209 I-chronic_disease

AIDS 0 4 210 214 B-chronic_disease
- 4 5 214 215 O
related 5 12 215 222 O
non 13 16 223 226 B-cancer
- 16 17 226 227 I-cancer
Hodgkin 17 24 227 234 I-cancer
lymphoma 25 33 235 243 I-cancer
and 34 37 244 247 O
other 38 43 248 253 O
non 44 47 254 257 O
- 47 48 257 258 O
Hodgkin 48 55 258 265 O
lymphoma 56 64 266 274 O

Active 0 6 275 281 B-chronic_disease
tuberculosis 7 19 282 294 I-chronic_disease
( 20 21 295 296 I-chronic_disease
TB 21 23 296 298 I-chronic_disease
) 23 24 298 299 I-chronic_disease

Cirrhosis 0 9 300 309 B-chronic_disease
with 10 14 310 314 O
Child 15 20 315 320 O
- 20 21 320 321 O
Pugh 21 25 321 325 O
score 26 31 326 331 O
of 32 34 332 334 O
B 35 36 335 336 O
or 37 39 337 339 O
C 40 41 340 341 O

Clinical 0 8 342 350 O
evidence 9 17 351 359 O
of 18 20 360 362 O
vitiligo 21 29 363 371 B-chronic_disease
or 30 32 372 374 O
other 33 38 375 380 O
forms 39 44 381 386 O
of 45 47 387 389 O
depigmenting 48 60 390 402 O
illness 61 68 403 410 O

Extensive 0 9 411 420 O
active 10 16 421 427 O
brain 17 22 428 433 B-chronic_disease
disease 23 30 434 441 I-chronic_disease
including 31 40 442 451 O
symptomatic 41 52 452 463 O
brain 53 58 464 469 B-cancer
metastases 59 69 470 480 I-cancer
or 70 72 481 483 O
the 73 76 484 487 O
presence 77 85 488 496 O
of 86 88 497 499 O
leptomeningeal 89 103 500 514 B-cancer
disease 104 111 515 522 I-cancer
, 111 112 522 523 O
and 113 116 524 527 O
all 117 120 528 531 O
patients 121 129 532 540 O
with 130 134 541 545 O
infratentorial 135 149 546 560 B-cancer
tumors 150 156 561 567 I-cancer

Failed 0 6 568 574 O
standard 7 15 575 583 O
first 16 21 584 589 O
- 21 22 589 590 O
line 22 26 590 594 O
therapy 27 34 595 602 B-treatment

Grade 0 5 603 608 O
3 6 7 609 610 O
or 8 10 611 613 O
4 11 12 614 615 O
immune 13 19 616 622 O
related 20 27 623 630 O
toxicity 28 36 631 639 O
associated 37 47 640 650 O
with 48 52 651 655 O
prior 53 58 656 661 B-treatment
ipilimumab 59 69 662 672 I-treatment
therapy 70 77 673 680 I-treatment
that 78 82 681 685 O
has 83 86 686 689 O
not 87 90 690 693 O
resolved 91 99 694 702 O
to 100 102 703 705 O
grade 103 108 706 711 O
0 109 110 712 713 O
or 111 113 714 716 O
1 114 115 717 718 O

Mild 0 4 719 723 O
autoimmunity 5 17 724 736 O
not 18 21 737 740 O
impacting 22 31 741 750 O
the 32 35 751 754 O
function 36 44 755 763 O
of 45 47 764 766 O
major 48 53 767 772 O
organs 54 60 773 779 O
( 61 62 780 781 O
e.g. 62 66 781 785 O
, 66 67 785 786 O
limited 68 75 787 794 O
psoriasis 76 85 795 804 B-chronic_disease
) 85 86 804 805 O

Patients 0 8 806 814 O
who 9 12 815 818 O
are 13 16 819 822 O
receiving 17 26 823 832 O
any 27 30 833 836 O
other 31 36 837 842 O
investigational 37 52 843 858 B-treatment
agents 53 59 859 865 I-treatment
for 60 63 866 869 O
cancer 64 70 870 876 B-cancer

Patients 0 8 877 885 O
who 9 12 886 889 O
are 13 16 890 893 O
undergoing 17 27 894 904 O
first 28 33 905 910 O
month 34 39 911 916 O
of 40 42 917 919 O
therapy 43 50 920 927 B-treatment
( 51 52 928 929 O
RIPE 52 56 929 933 B-treatment
or 57 59 934 936 O
equivalent 60 70 937 947 O
) 70 71 947 948 O
for 72 75 949 952 O
active 76 82 953 959 O
TB 83 85 960 962 B-chronic_disease

Patients 0 8 963 971 O
who 9 12 972 975 O
have 13 17 976 980 O
been 18 22 981 985 O
successfully 23 35 986 998 O
treated 36 43 999 1006 O
for 44 47 1007 1010 O
HCV 48 51 1011 1014 B-chronic_disease
as 52 54 1015 1017 O
long 55 59 1018 1022 O
as 60 62 1023 1025 O
therapy 63 70 1026 1033 B-treatment
for 71 74 1034 1037 O
HCV 75 78 1038 1041 O
has 79 82 1042 1045 O
been 83 87 1046 1050 O
completed 88 97 1051 1060 O

Patients 0 8 1061 1069 O
with 9 13 1070 1074 O
TB 14 16 1075 1077 B-chronic_disease
immune 17 23 1078 1084 I-chronic_disease
reconstitution 24 38 1085 1099 I-chronic_disease
syndrome 39 47 1100 1108 I-chronic_disease
( 48 49 1109 1110 O
IRIS 49 53 1110 1114 O
) 53 54 1114 1115 O
requiring 55 64 1116 1125 O
corticosteroids 65 80 1126 1141 B-treatment

Patients 0 8 1142 1150 O
with 9 13 1151 1155 O
chronic 14 21 1156 1163 O
HBV 22 25 1164 1167 B-chronic_disease
suppressed 26 36 1168 1178 O
by 37 39 1179 1181 O
appropriate 40 51 1182 1193 O
antiretroviral 52 66 1194 1208 B-treatment
therapy 67 74 1209 1216 I-treatment
with 75 79 1217 1221 O
activity 80 88 1222 1230 O
against 89 96 1231 1238 O
HBV 97 100 1239 1242 O
, 100 101 1242 1243 O
as 102 104 1244 1246 O
outlined 105 113 1247 1255 O
in 114 116 1256 1258 O
DHHS 117 121 1259 1263 O
guidelines 122 132 1264 1274 O

Positive 0 8 1275 1283 O
HCV 9 12 1284 1287 B-chronic_disease
serology 13 21 1288 1296 O
but 22 25 1297 1300 O
no 26 28 1301 1303 O
detectable 29 39 1304 1314 O
HCV 40 43 1315 1318 O
RNA 44 47 1319 1322 O
, 47 48 1322 1323 O
indicative 49 59 1324 1334 O
of 60 62 1335 1337 O
spontaneously 63 76 1338 1351 O
cleared 77 84 1352 1359 O
HCV 85 88 1360 1363 B-chronic_disease
infection 89 98 1364 1373 I-chronic_disease

The 0 3 1374 1377 O
presence 4 12 1378 1386 O
of 13 15 1387 1389 O
laboratory 16 26 1390 1400 O
evidence 27 35 1401 1409 O
of 36 38 1410 1412 O
autoimmune 39 49 1413 1423 B-chronic_disease
disease 50 57 1424 1431 I-chronic_disease
( 58 59 1432 1433 O
e.g. 59 63 1433 1437 O
, 63 64 1437 1438 O
positive 65 73 1439 1447 O
antinuclear 74 85 1448 1459 O
antibody 86 94 1460 1468 O
[ 95 96 1469 1470 O
ANA 96 99 1470 1473 O
] 99 100 1473 1474 O
titer 101 106 1475 1480 O
or 107 109 1481 1483 O
lupus 110 115 1484 1489 B-chronic_disease
anticoagulant 116 129 1490 1503 O
) 129 130 1503 1504 O
without 131 138 1505 1512 O
associated 139 149 1513 1523 O
symptoms 150 158 1524 1532 O

Uncontrolled 0 12 1533 1545 O
hepatitis 13 22 1546 1555 B-chronic_disease
B 23 24 1556 1557 I-chronic_disease
virus 25 30 1558 1563 I-chronic_disease
( 31 32 1564 1565 I-chronic_disease
HBV 32 35 1565 1568 I-chronic_disease
) 35 36 1568 1569 I-chronic_disease
infection 37 46 1570 1579 I-chronic_disease
, 46 47 1579 1580 O
defined 48 55 1581 1588 O
as 56 58 1589 1591 O
plasma 59 65 1592 1598 O
HBV 66 69 1599 1602 O
DNA 70 73 1603 1606 O
detectable 74 84 1607 1617 O
by 85 87 1618 1620 O
polymerase 88 98 1621 1631 O
chain 99 104 1632 1637 O
reaction 105 113 1638 1646 O
( 114 115 1647 1648 O
PCR 115 118 1648 1651 O
) 118 119 1651 1652 O

Uncontrolled 0 12 1653 1665 O
hepatitis 13 22 1666 1675 B-chronic_disease
C 23 24 1676 1677 I-chronic_disease
virus 25 30 1678 1683 O
( 31 32 1684 1685 O
HCV 32 35 1685 1688 B-chronic_disease
) 35 36 1688 1689 O
infection 37 46 1690 1699 O
, 46 47 1699 1700 O
defined 48 55 1701 1708 O
as 56 58 1709 1711 O
plasma 59 65 1712 1718 O
HCV 66 69 1719 1722 O
RNA 70 73 1723 1726 O
detectable 74 84 1727 1737 O
by 85 87 1738 1740 O
PCR 88 91 1741 1744 O

active 0 6 1745 1751 O
angina 7 13 1752 1758 B-chronic_disease
pectoris 14 22 1759 1767 I-chronic_disease

congestive 0 10 1768 1778 B-chronic_disease
heart 11 16 1779 1784 I-chronic_disease
failure 17 24 1785 1792 I-chronic_disease
( 25 26 1793 1794 O
New 26 29 1794 1797 B-clinical_variable
York 30 34 1798 1802 I-clinical_variable
Heart 35 40 1803 1808 I-clinical_variable
Association 41 52 1809 1820 I-clinical_variable
class 53 58 1821 1826 I-clinical_variable
III 59 62 1827 1830 B-lower_bound
or 63 65 1831 1833 O
IV 66 68 1834 1836 B-upper_bound
) 68 69 1836 1837 O

patients 0 8 1838 1846 O
who 9 12 1847 1850 O
are 13 16 1851 1854 O
receiving 17 26 1855 1864 O
therapy 27 34 1865 1872 B-treatment
beyond 35 41 1873 1879 O
month 42 47 1880 1885 B-lower_bound
one 48 51 1886 1889 I-lower_bound
of 52 54 1890 1892 O
initial 55 62 1893 1900 B-treatment
therapy 63 70 1901 1908 I-treatment
with 71 75 1909 1913 O
no 76 78 1914 1916 O
evidence 79 87 1917 1925 O
of 88 90 1926 1928 O
TB 91 93 1929 1931 B-chronic_disease
IRIS 94 98 1932 1936 I-chronic_disease
requiring 99 108 1937 1946 O
corticosteroid 109 123 1947 1961 B-treatment
therapy 124 131 1962 1969 I-treatment
, 131 132 1969 1970 O
or 133 135 1971 1973 O
those 136 141 1974 1979 O
receiving 142 151 1980 1989 O
treatment 152 161 1990 1999 B-treatment
for 162 165 2000 2003 O
latent 166 172 2004 2010 B-chronic_disease
tuberculosis 173 185 2011 2023 I-chronic_disease
( 186 187 2024 2025 O
INH 187 190 2025 2028 O
or 191 193 2029 2031 O
alternative 194 205 2032 2043 O
) 205 206 2043 2044 O
may 207 210 2045 2048 O
be 211 213 2049 2051 O
eligible 214 222 2052 2060 O
after 223 228 2061 2066 O
discussion 229 239 2067 2077 O
with 240 244 2078 2082 O
the 245 248 2083 2086 O
protocol 249 257 2087 2095 O
P.I 258 261 2096 2099 O

recent 0 6 2100 2106 O
myocardial 7 17 2107 2117 B-chronic_disease
infarction 18 28 2118 2128 I-chronic_disease
( 29 30 2129 2130 O
within 30 36 2130 2136 O
the 37 40 2137 2140 O
last 41 45 2141 2145 B-upper_bound
6 46 47 2146 2147 I-upper_bound
months 48 54 2148 2154 I-upper_bound
) 54 55 2154 2155 O

